{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:11:53Z","timestamp":1794863513745,"version":"4.9.1"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41581-025-01020-6","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:21:09Z","timestamp":1762881669000},"page":"137-151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The genetics of hypertension"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2339-0545","authenticated-orcid":false,"given":"Gabriel","family":"St\u00f6lting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieu Nhi","family":"Tran Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janek","family":"Haus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute I.","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"1020_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2024.05.033","volume":"126","author":"R Kreutz","year":"2024","unstructured":"Kreutz, R. et al. 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension. Eur. J. Intern. Med. 126, 1\u201315 (2024).","journal-title":"Eur. J. Intern. Med."},{"key":"1020_CR2","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy, J. W. et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur. Heart J. 45, 3912\u20134018 (2024).","journal-title":"Eur. Heart J."},{"key":"1020_CR3","first-page":"e114","volume":"152","author":"M Writing Committee","year":"2025","unstructured":"Writing Committee, M. et al. 2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation 152, e114\u2013e218 (2025).","journal-title":"Circulation"},{"key":"1020_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"NCD Risk Factor Collaboration","year":"2021","unstructured":"NCD Risk Factor Collaboration Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 398, 957\u2013980 (2021).","journal-title":"Lancet"},{"key":"1020_CR5","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","unstructured":"GBD 2019 Risk Factors Collaborators Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet 396, 1223\u20131249 (2020).","journal-title":"Lancet"},{"key":"1020_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2016.19043","volume":"317","author":"MH Forouzanfar","year":"2017","unstructured":"Forouzanfar, M. H. et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990\u20132015. JAMA 317, 165\u2013182 (2017).","journal-title":"JAMA"},{"key":"1020_CR7","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington, S. et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903\u20131913 (2002).","journal-title":"Lancet"},{"key":"1020_CR8","first-page":"1229","volume":"39","author":"FJ Rios","year":"2023","unstructured":"Rios, F. J., Montezano, A. C., Camargo, L. L. & Touyz, R. M. Impact of environmental factors on hypertension and associated cardiovascular disease. Can. J. Cardiol. 39, 1229\u20131243 (2023).","journal-title":"Can. J. Cardiol."},{"key":"1020_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/HJH.0000000000003563","volume":"42","author":"FJ Charchar","year":"2024","unstructured":"Charchar, F. J. et al. Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension. J. Hypertens. 42, 23\u201349 (2024).","journal-title":"J. Hypertens."},{"key":"1020_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41581-022-00654-0","volume":"19","author":"JA O\u2019Donnell","year":"2023","unstructured":"O\u2019Donnell, J. A., Zheng, T., Meric, G. & Marques, F. Z. The gut microbiome and hypertension. Nat. Rev. Nephrol. 19, 153\u2013167 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"1020_CR11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1161\/01.HYP.37.2.350","volume":"37","author":"FC Luft","year":"2001","unstructured":"Luft, F. C. Twins in cardiovascular genetic research. Hypertension 37, 350\u2013356 (2001).","journal-title":"Hypertension"},{"key":"1020_CR12","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1161\/CIRCRESAHA.116.303647","volume":"116","author":"S Padmanabhan","year":"2015","unstructured":"Padmanabhan, S., Caulfield, M. & Dominiczak, A. F. Genetic and molecular aspects of hypertension. Circ. Res. 116, 937\u2013959 (2015).","journal-title":"Circ. Res."},{"key":"1020_CR13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/CIRCULATIONAHA.117.030898","volume":"137","author":"R Pazoki","year":"2018","unstructured":"Pazoki, R. et al. Genetic predisposition to high blood pressure and lifestyle factors: associations with midlife blood pressure levels and cardiovascular events. Circulation 137, 653\u2013661 (2018).","journal-title":"Circulation"},{"key":"1020_CR14","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvae041","volume":"190","author":"P Mulatero","year":"2024","unstructured":"Mulatero, P. et al. Familial hyperaldosteronism: an European Reference Network on Rare Endocrine Conditions clinical practice guideline. Eur. J. Endocrinol. 190, G1\u2013G14 (2024).","journal-title":"Eur. J. Endocrinol."},{"key":"1020_CR15","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","volume":"110","author":"GK Adler","year":"2025","unstructured":"Adler, G. K. et al. Primary aldosteronism: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 110, 2453\u20132495 (2025).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1020_CR16","first-page":"1109","volume":"95","author":"DJ Sutherland","year":"1966","unstructured":"Sutherland, D. J., Ruse, J. L. & Laidlaw, J. C. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can. Med. Assoc. J. 95, 1109\u20131119 (1966).","journal-title":"Can. Med. Assoc. J."},{"key":"1020_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"Lifton, R. P. et al. A chimaeric 11 \u03b2-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355, 262\u2013265 (1992).","journal-title":"Nature"},{"key":"1020_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","volume":"50","author":"UI Scholl","year":"2018","unstructured":"Scholl, U. I. et al. CLCN2 chloride channel mutations in familial hyperaldosteronism type II. Nat. Genet. 50, 349\u2013354 (2018).","journal-title":"Nat. Genet."},{"key":"1020_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41588-018-0053-8","volume":"50","author":"FL Fernandes-Rosa","year":"2018","unstructured":"Fernandes-Rosa, F. L. et al. A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism. Nat. Genet. 50, 355\u2013361 (2018).","journal-title":"Nat. Genet."},{"key":"1020_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13033-4","volume":"10","author":"J Schewe","year":"2019","unstructured":"Schewe, J. et al. Elevated aldosterone and blood pressure in a mouse model of familial hyperaldosteronism with ClC-2 mutation. Nat. Commun. 10, 5155 (2019).","journal-title":"Nat. Commun."},{"key":"1020_CR21","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1198785","volume":"331","author":"M Choi","year":"2011","unstructured":"Choi, M. et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331, 768\u2013772 (2011).","journal-title":"Science"},{"key":"1020_CR22","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1073\/pnas.1121407109","volume":"109","author":"UI Scholl","year":"2012","unstructured":"Scholl, U. I. et al. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc. Natl Acad. Sci. USA 109, 2533\u20132538 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1020_CR23","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06315","volume":"4","author":"UI Scholl","year":"2015","unstructured":"Scholl, U. I. et al. Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. eLife 4, e06315 (2015).","journal-title":"eLife"},{"key":"1020_CR24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2014876118","volume":"118","author":"E Seidel","year":"2021","unstructured":"Seidel, E. et al. Enhanced Ca2+ signaling, mild primary aldosteronism, and hypertension in a familial hyperaldosteronism mouse model (Cacna1hM1560V\/+). Proc. Natl Acad. Sci. USA 118, e2014876118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1020_CR25","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/ng.2695","volume":"45","author":"UI Scholl","year":"2013","unstructured":"Scholl, U. I. et al. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat. Genet. 45, 1050\u20131054 (2013).","journal-title":"Nat. Genet."},{"key":"1020_CR26","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.162468","volume":"8","author":"G Stolting","year":"2023","unstructured":"Stolting, G. et al. Isradipine therapy in Cacna1dIle772Met\/+ mice ameliorates primary aldosteronism and neurologic abnormalities. JCI Insight 8, e162468 (2023).","journal-title":"JCI Insight"},{"key":"1020_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00424-020-02418-w","volume":"472","author":"NJ Ortner","year":"2020","unstructured":"Ortner, N. J., Kaserer, T., Copeland, J. N. & Striessnig, J. De novo CACNA1D Ca2+ channelopathies: clinical phenotypes and molecular mechanism. Pflugers Arch. 472, 755\u2013773 (2020).","journal-title":"Pflugers Arch."},{"key":"1020_CR28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/ejhg.2013.197","volume":"22","author":"S Menabo","year":"2014","unstructured":"Menabo, S. et al. Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations. Eur. J. Hum. Genet. 22, 610\u2013616 (2014).","journal-title":"Eur. J. Hum. Genet."},{"key":"1020_CR29","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1172\/JCI115182","volume":"87","author":"PC White","year":"1991","unstructured":"White, P. C. et al. A mutation in CYP11B1 (Arg-448\u2013His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin. J. Clin. Invest. 87, 1664\u20131667 (1991).","journal-title":"J. Clin. Invest."},{"key":"1020_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jsbmb.2016.02.002","volume":"165","author":"RJ Auchus","year":"2017","unstructured":"Auchus, R. J. Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic. J. Steroid Biochem. Mol. Biol. 165, 71\u201378 (2017).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"1020_CR31","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1210\/mend-2-6-564","volume":"2","author":"M Kagimoto","year":"1988","unstructured":"Kagimoto, M., Winter, J. S., Kagimoto, K., Simpson, E. R. & Waterman, M. R. Structural characterization of normal and mutant human steroid 17 \u03b1-hydroxylase genes: molecular basis of one example of combined 17 \u03b1-hydroxylase\/17,20 lyase deficiency. Mol. Endocrinol. 2, 564\u2013570 (1988).","journal-title":"Mol. Endocrinol."},{"key":"1020_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/ng0895-394","volume":"10","author":"T Mune","year":"1995","unstructured":"Mune, T., Rogerson, F. M., Nikkila, H., Agarwal, A. K. & White, P. C. Human hypertension caused by mutations in the kidney isozyme of 11 \u03b2-hydroxysteroid dehydrogenase. Nat. Genet. 10, 394\u2013399 (1995).","journal-title":"Nat. Genet."},{"key":"1020_CR33","doi-asserted-by":"publisher","first-page":"dgz315","DOI":"10.1210\/clinem\/dgz315","volume":"105","author":"CA Carvajal","year":"2020","unstructured":"Carvajal, C. A., Tapia-Castillo, A., Vecchiola, A., Baudrand, R. & Fardella, C. E. Classic and nonclassic apparent mineralocorticoid excess syndrome. J. Clin. Endocrinol. Metab. 105, dgz315 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1020_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03698-9","volume":"20","author":"YT Lu","year":"2022","unstructured":"Lu, Y. T. et al. Apparent mineralocorticoid excess: comprehensive overview of molecular genetics. J. Transl Med. 20, 500 (2022).","journal-title":"J. Transl Med."},{"key":"1020_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1126\/science.289.5476.119","volume":"289","author":"DS Geller","year":"2000","unstructured":"Geller, D. S. et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289, 119\u2013123 (2000).","journal-title":"Science"},{"key":"1020_CR36","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1210\/en.2002-220708","volume":"144","author":"ME Rafestin-Oblin","year":"2003","unstructured":"Rafestin-Oblin, M. E. et al. The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related. Endocrinology 144, 528\u2013533 (2003).","journal-title":"Endocrinology"},{"key":"1020_CR37","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1210\/jcem-43-5-1128","volume":"43","author":"AC Vingerhoeds","year":"1976","unstructured":"Vingerhoeds, A. C., Thijssen, J. H. & Schwarz, F. Spontaneous hypercortisolism without Cushing\u2019s syndrome. J. Clin. Endocrinol. Metab. 43, 1128\u20131133 (1976).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1020_CR38","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1172\/JCI115046","volume":"87","author":"DM Hurley","year":"1991","unstructured":"Hurley, D. M. et al. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J. Clin. Invest. 87, 680\u2013686 (1991).","journal-title":"J. Clin. Invest."},{"key":"1020_CR39","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ecl.2018.02.007","volume":"47","author":"LC Hernandez-Ramirez","year":"2018","unstructured":"Hernandez-Ramirez, L. C. & Stratakis, C. A. Genetics of Cushing\u2019s syndrome. Endocrinol. Metab. Clin. North. Am. 47, 275\u2013297 (2018).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"1020_CR40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5694\/j.1326-5377.1964.tb115766.x","volume":"2","author":"WK Paver","year":"1964","unstructured":"Paver, W. K. & Pauline, G. J. Hypertension and hyperpotassaemia without renal disease in a young male. Med. J. Aust. 2, 305\u2013306 (1964).","journal-title":"Med. J. Aust."},{"key":"1020_CR41","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.5694\/j.1326-5377.1968.tb83401.x","volume":"2","author":"GS Stokes","year":"1968","unstructured":"Stokes, G. S., Gentle, J. L., Edwards, K. D. & Stewart, J. H. Syndrome of idiopathic hyperkalaemia and hypertension with decreased plasma renin activity: effects on plasma renin and aldosterone of reducing the serum potassium level. Med. J. Aust. 2, 1050\u20131054 (1968).","journal-title":"Med. J. Aust."},{"key":"1020_CR42","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1126\/science.1062844","volume":"293","author":"FH Wilson","year":"2001","unstructured":"Wilson, F. H. et al. Human hypertension caused by mutations in WNK kinases. Science 293, 1107\u20131112 (2001).","journal-title":"Science"},{"key":"1020_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature10814","volume":"482","author":"LM Boyden","year":"2012","unstructured":"Boyden, L. M. et al. Mutations in Kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482, 98\u2013102 (2012).","journal-title":"Nature"},{"key":"1020_CR44","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/ng.2218","volume":"44","author":"H Louis-Dit-Picard","year":"2012","unstructured":"Louis-Dit-Picard, H. et al. KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat. Genet. 44, 456\u2013460\u00a0(2012).","journal-title":"Nat. Genet."},{"key":"1020_CR45","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41440-020-0437-x","volume":"43","author":"T Furusho","year":"2020","unstructured":"Furusho, T., Uchida, S. & Sohara, E. The WNK signaling pathway and salt-sensitive hypertension. Hypertens. Res. 43, 733\u2013743 (2020).","journal-title":"Hypertens. Res."},{"key":"1020_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1161\/HYPERTENSIONAHA.117.10491","volume":"71","author":"L Pagani","year":"2018","unstructured":"Pagani, L. et al. Three reportedly unrelated families with Liddle syndrome inherited from a common ancestor. Hypertension 71, 273\u2013279 (2018).","journal-title":"Hypertension"},{"key":"1020_CR47","first-page":"199","volume":"76","author":"L Gw","year":"1966","unstructured":"Gw, L. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans. Assoc. Physicians 76, 199\u2013213 (1966).","journal-title":"Trans. Assoc. Physicians"},{"key":"1020_CR48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0092-8674(94)90250-X","volume":"79","author":"RA Shimkets","year":"1994","unstructured":"Shimkets, R. A. et al. Liddle\u2019s syndrome: heritable human hypertension caused by mutations in the \u03b2 subunit of the epithelial sodium channel. Cell 79, 407\u2013414 (1994).","journal-title":"Cell"},{"key":"1020_CR49","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ng0995-76","volume":"11","author":"JH Hansson","year":"1995","unstructured":"Hansson, J. H. et al. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat. Genet. 11, 76\u201382 (1995).","journal-title":"Nat. Genet."},{"key":"1020_CR50","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1681\/ASN.2016111163","volume":"28","author":"M Salih","year":"2017","unstructured":"Salih, M. et al. A missense mutation in the extracellular domain of \u03b1ENaC causes Liddle syndrome. J. Am. Soc. Nephrol. 28, 3291\u20133299 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1020_CR51","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1056\/NEJM200102083440607","volume":"344","author":"RD Safian","year":"2001","unstructured":"Safian, R. D. & Textor, S. C. Renal-artery stenosis. N. Engl. J. Med. 344, 431\u2013442 (2001).","journal-title":"N. Engl. J. Med."},{"key":"1020_CR52","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/jmg.10.3.253","volume":"10","author":"N Bilginturan","year":"1973","unstructured":"Bilginturan, N., Zileli, S., Karacadag, S. & Pirnar, T. Hereditary brachydactyly associated with hypertension. J. Med. Genet. 10, 253\u2013259 (1973).","journal-title":"J. Med. Genet."},{"key":"1020_CR53","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/HYPERTENSIONAHA.110.156620","volume":"56","author":"O Toka","year":"2010","unstructured":"Toka, O. et al. Childhood hypertension in autosomal-dominant hypertension with brachydactyly. Hypertension 56, 988\u2013994 (2010).","journal-title":"Hypertension"},{"key":"1020_CR54","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/ng.3302","volume":"47","author":"PG Maass","year":"2015","unstructured":"Maass, P. G. et al. PDE3A mutations cause autosomal dominant hypertension with brachydactyly. Nat. Genet. 47, 647\u2013653 (2015).","journal-title":"Nat. Genet."},{"key":"1020_CR55","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1161\/CIRCULATIONAHA.119.043061","volume":"142","author":"M Ercu","year":"2020","unstructured":"Ercu, M. et al. Phosphodiesterase 3A and arterial hypertension. Circulation 142, 133\u2013149 (2020).","journal-title":"Circulation"},{"key":"1020_CR56","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/ng1221","volume":"34","author":"F Rutsch","year":"2003","unstructured":"Rutsch, F. et al. Mutations in ENPP1 are associated with \u2018idiopathic\u2019 infantile arterial calcification. Nat. Genet. 34, 379\u2013381 (2003).","journal-title":"Nat. Genet."},{"key":"1020_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ajhg.2011.11.020","volume":"90","author":"Y Nitschke","year":"2012","unstructured":"Nitschke, Y. et al. Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am. J. Hum. Genet. 90, 25\u201339 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"1020_CR58","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2016.11.008","volume":"100","author":"DC Guo","year":"2017","unstructured":"Guo, D. C. et al. Loss-of-function mutations in YY1AP1 Lead to grange syndrome and a fibromuscular dysplasia-like vascular disease. Am. J. Hum. Genet. 100, 21\u201330 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"1020_CR59","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/ajmg.a.60700","volume":"179","author":"M Rath","year":"2019","unstructured":"Rath, M. et al. Identification of pathogenic YY1AP1 splice variants in siblings with Grange syndrome by whole exome sequencing. Am. J. Med. Genet. A 179, 295\u2013299 (2019).","journal-title":"Am. J. Med. Genet. A"},{"key":"1020_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/j.2040-4603.2015.tb00599.x","volume":"5","author":"AW Tank","year":"2015","unstructured":"Tank, A. W. & Lee Wong, D. Peripheral and central effects of circulating catecholamines. Compr. Physiol. 5, 1\u201315 (2015).","journal-title":"Compr. Physiol."},{"key":"1020_CR61","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1530\/EO-22-0044","volume":"2","author":"CG Turin","year":"2022","unstructured":"Turin, C. G., Crenshaw, M. M. & Fishbein, L. Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes. Endocr. Oncol. 2, R65\u2013R77 (2022).","journal-title":"Endocr. Oncol."},{"key":"1020_CR62","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","volume":"19","author":"N Burnichon","year":"2010","unstructured":"Burnichon, N. et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum. Mol. Genet. 19, 3011\u20133020 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"1020_CR63","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1086\/321282","volume":"69","author":"D Astuti","year":"2001","unstructured":"Astuti, D. et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet. 69, 49\u201354 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"1020_CR64","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/81551","volume":"26","author":"S Niemann","year":"2000","unstructured":"Niemann, S. & Muller, U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat. Genet. 26, 268\u2013270 (2000).","journal-title":"Nat. Genet."},{"key":"1020_CR65","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.287.5454.848","volume":"287","author":"BE Baysal","year":"2000","unstructured":"Baysal, B. E. et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287, 848\u2013851 (2000).","journal-title":"Science"},{"key":"1020_CR66","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1126\/science.1175689","volume":"325","author":"HX Hao","year":"2009","unstructured":"Hao, H. X. et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325, 1139\u20131142 (2009).","journal-title":"Science"},{"key":"1020_CR67","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ajhg.2019.02.017","volume":"104","author":"L Remacha","year":"2019","unstructured":"Remacha, L. et al. Recurrent germline DLST mutations in individuals with multiple pheochromocytomas and paragangliomas. Am. J. Hum. Genet. 104, 651\u2013664 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"1020_CR68","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1158\/0008-5472.CAN-17-2463","volume":"78","author":"A Buffet","year":"2018","unstructured":"Buffet, A. et al. Germline mutations in the mitochondrial 2-oxoglutarate\/malate carrier SLC25A11 gene confer a predisposition to metastatic paragangliomas. Cancer Res. 78, 1914\u20131922 (2018).","journal-title":"Cancer Res."},{"key":"1020_CR69","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00109-012-0967-z","volume":"91","author":"FR Lorenzo","year":"2013","unstructured":"Lorenzo, F. R. et al. A novel EPAS1\/HIF2A germline mutation in a congenital polycythemia with paraganglioma. J. Mol. Med. 91, 507\u2013512 (2013).","journal-title":"J. Mol. Med."},{"key":"1020_CR70","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1056\/NEJMoa020152","volume":"346","author":"HP Neumann","year":"2002","unstructured":"Neumann, H. P. et al. Germ-line mutations in nonsyndromic pheochromocytoma. N. Engl. J. Med. 346, 1459\u20131466 (2002).","journal-title":"N. Engl. J. Med."},{"key":"1020_CR71","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1136\/jmg.32.12.934","volume":"32","author":"C Eng","year":"1995","unstructured":"Eng, C. et al. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. J. Med. Genet. 32, 934\u2013937 (1995).","journal-title":"J. Med. Genet."},{"key":"1020_CR72","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00125817-200205000-00002","volume":"4","author":"JM Friedman","year":"2002","unstructured":"Friedman, J. M. et al. Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force. Genet. Med. 4, 105\u2013111 (2002).","journal-title":"Genet. Med."},{"key":"1020_CR73","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ng.861","volume":"43","author":"I Comino-Mendez","year":"2011","unstructured":"Comino-Mendez, I. et al. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat. Genet. 43, 663\u2013667 (2011).","journal-title":"Nat. Genet."},{"key":"1020_CR74","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ng.533","volume":"42","author":"Y Qin","year":"2010","unstructured":"Qin, Y. et al. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat. Genet. 42, 229\u2013233 (2010).","journal-title":"Nat. Genet."},{"key":"1020_CR75","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ng0696-183","volume":"13","author":"DB Simon","year":"1996","unstructured":"Simon, D. B. et al. Bartter\u2019s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat. Genet. 13, 183\u2013188 (1996).","journal-title":"Nat. Genet."},{"key":"1020_CR76","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ng1096-152","volume":"14","author":"DB Simon","year":"1996","unstructured":"Simon, D. B. et al. Genetic heterogeneity of Bartter\u2019s syndrome revealed by mutations in the K+ channel, ROMK. Nat. Genet. 14, 152\u2013156 (1996).","journal-title":"Nat. Genet."},{"key":"1020_CR77","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng1097-171","volume":"17","author":"DB Simon","year":"1997","unstructured":"Simon, D. B. et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter\u2019s syndrome type III. Nat. Genet. 17, 171\u2013178 (1997).","journal-title":"Nat. Genet."},{"key":"1020_CR78","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng752","volume":"29","author":"R Birkenhager","year":"2001","unstructured":"Birkenhager, R. et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat. Genet. 29, 310\u2013314 (2001).","journal-title":"Nat. Genet."},{"key":"1020_CR79","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1056\/NEJMoa032843","volume":"350","author":"KP Schlingmann","year":"2004","unstructured":"Schlingmann, K. P. et al. Salt wasting and deafness resulting from mutations in two chloride channels. N. Engl. J. Med. 350, 1314\u20131319 (2004).","journal-title":"N. Engl. J. Med."},{"key":"1020_CR80","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1056\/NEJMoa1507629","volume":"374","author":"K Laghmani","year":"2016","unstructured":"Laghmani, K. et al. Polyhydramnios, transient antenatal Bartter\u2019s syndrome, and MAGED2 mutations. N. Engl. J. Med. 374, 1853\u20131863 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1020_CR81","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0002-9343(62)90214-0","volume":"33","author":"FC Bartter","year":"1962","unstructured":"Bartter, F. C., Pronove, P., Gill, J. R. Jr. & Maccardle, R. C. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am. J. Med. 33, 811\u2013828 (1962).","journal-title":"Am. J. Med."},{"key":"1020_CR82","first-page":"221","volume":"79","author":"HJ Gitelman","year":"1966","unstructured":"Gitelman, H. J., Graham, J. B. & Welt, L. G. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans. Assoc. Am. Physicians 79, 221\u2013235 (1966).","journal-title":"Trans. Assoc. Am. Physicians"},{"key":"1020_CR83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng0196-24","volume":"12","author":"DB Simon","year":"1996","unstructured":"Simon, D. B. et al. Gitelman\u2019s variant of Bartter\u2019s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat. Genet. 12, 24\u201330 (1996).","journal-title":"Nat. Genet."},{"key":"1020_CR84","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/adc.33.169.252","volume":"33","author":"DB Cheek","year":"1958","unstructured":"Cheek, D. B. & Perry, J. W. A salt wasting syndrome in infancy. Arch. Dis. Child. 33, 252\u2013256 (1958).","journal-title":"Arch. Dis. Child."},{"key":"1020_CR85","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/966","volume":"19","author":"DS Geller","year":"1998","unstructured":"Geller, D. S. et al. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat. Genet. 19, 279\u2013281 (1998).","journal-title":"Nat. Genet."},{"key":"1020_CR86","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/ng0396-248","volume":"12","author":"SS Chang","year":"1996","unstructured":"Chang, S. S. et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat. Genet. 12, 248\u2013253 (1996).","journal-title":"Nat. Genet."},{"key":"1020_CR87","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/ng0696-248","volume":"13","author":"SS Strautnieks","year":"1996","unstructured":"Strautnieks, S. S., Thompson, R. J., Gardiner, R. M. & Chung, E. A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families. Nat. Genet. 13, 248\u2013250 (1996).","journal-title":"Nat. Genet."},{"key":"1020_CR88","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","volume":"106","author":"TA Williams","year":"2021","unstructured":"Williams, T. A. et al. International histopathology consensus for unilateral primary aldosteronism. J. Clin. Endocrinol. Metab. 106, 42\u201354 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1020_CR89","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder, J. W. et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 1889\u20131916 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1020_CR90","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ng.2550","volume":"45","author":"F Beuschlein","year":"2013","unstructured":"Beuschlein, F. et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat. Genet. 45, 440\u2013444 (2013).","journal-title":"Nat. Genet."},{"key":"1020_CR91","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/HYPERTENSIONAHA.121.16498","volume":"79","author":"UI Scholl","year":"2022","unstructured":"Scholl, U. I. Genetics of primary aldosteronism. Hypertension 79, 887\u2013897 (2022).","journal-title":"Hypertension"},{"key":"1020_CR92","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ng.2716","volume":"45","author":"EA Azizan","year":"2013","unstructured":"Azizan, E. A. et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat. Genet. 45, 1055\u20131060 (2013).","journal-title":"Nat. Genet."},{"key":"1020_CR93","doi-asserted-by":"publisher","first-page":"K37","DOI":"10.1530\/EJE-19-0377","volume":"181","author":"RK Dutta","year":"2019","unstructured":"Dutta, R. K. et al. A somatic mutation in CLCN2 identified in a sporadic aldosterone-producing adenoma. Eur. J. Endocrinol. 181, K37\u2013K41 (2019).","journal-title":"Eur. J. Endocrinol."},{"key":"1020_CR94","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/HYPERTENSIONAHA.119.14349","volume":"75","author":"K Nanba","year":"2020","unstructured":"Nanba, K. et al. Somatic CACNA1H mutation as a cause of aldosterone-producing adenoma. Hypertension 75, 645\u2013649 (2020).","journal-title":"Hypertension"},{"key":"1020_CR95","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41588-023-01498-5","volume":"55","author":"J Rege","year":"2023","unstructured":"Rege, J. et al. Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism. Nat. Genet. 55, 1623\u20131631 (2023).","journal-title":"Nat. Genet."},{"key":"1020_CR96","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41588-023-01403-0","volume":"55","author":"X Wu","year":"2023","unstructured":"Wu, X. et al. Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production. Nat. Genet. 55, 1009\u20131021 (2023).","journal-title":"Nat. Genet."},{"key":"1020_CR97","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1365-2265.2007.03033.x","volume":"68","author":"M Tadjine","year":"2008","unstructured":"Tadjine, M., Lampron, A., Ouadi, L. & Bourdeau, I. Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas. Clin. Endocrinol. 68, 264\u2013270 (2008).","journal-title":"Clin. Endocrinol."},{"key":"1020_CR98","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1038\/s41588-021-00906-y","volume":"53","author":"J Zhou","year":"2021","unstructured":"Zhou, J. et al. Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause. Nat. Genet. 53, 1360\u20131372 (2021).","journal-title":"Nat. Genet."},{"key":"1020_CR99","doi-asserted-by":"publisher","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","volume":"112","author":"K Nishimoto","year":"2015","unstructured":"Nishimoto, K. et al. Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands. Proc. Natl Acad. Sci. USA 112, E4591\u2013E4599 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1020_CR100","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","volume":"72","author":"K Omata","year":"2018","unstructured":"Omata, K. et al. Cellular and genetic causes of idiopathic hyperaldosteronism. Hypertension 72, 874\u2013880 (2018).","journal-title":"Hypertension"},{"key":"1020_CR101","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1210\/jc.2015-3285","volume":"101","author":"K Nishimoto","year":"2016","unstructured":"Nishimoto, K. et al. Case report: nodule development from subcapsular aldosterone-producing cell clusters causes hyperaldosteronism. J. Clin. Endocrinol. Metab. 101, 6\u20139 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1020_CR102","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jama.2023.11305","volume":"330","author":"M Reincke","year":"2023","unstructured":"Reincke, M. & Fleseriu, M. Cushing syndrome: a review. JAMA 330, 170\u2013181 (2023).","journal-title":"JAMA"},{"key":"1020_CR103","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng.3166","volume":"47","author":"M Reincke","year":"2015","unstructured":"Reincke, M. et al. Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease. Nat. Genet. 47, 31\u201338 (2015).","journal-title":"Nat. Genet."},{"key":"1020_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05275-5","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen, J. et al. Identification of recurrent USP48 and BRAF mutations in Cushing\u2019s disease. Nat. Commun. 9, 3171 (2018).","journal-title":"Nat. Commun."},{"key":"1020_CR105","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1530\/ERC-17-0131","volume":"24","author":"LC Hernandez-Ramirez","year":"2017","unstructured":"Hernandez-Ramirez, L. C. et al. Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing\u2019s disease. Endocr. Relat. Cancer 24, 379\u2013392 (2017).","journal-title":"Endocr. Relat. Cancer"},{"key":"1020_CR106","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","volume":"370","author":"F Beuschlein","year":"2014","unstructured":"Beuschlein, F. et al. Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome. N. Engl. J. Med. 370, 1019\u20131028 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1020_CR107","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","volume":"65","author":"F Tissier","year":"2005","unstructured":"Tissier, F. et al. Mutations of \u03b2-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res. 65, 7622\u20137627 (2005).","journal-title":"Cancer Res."},{"key":"1020_CR108","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","volume":"38","author":"JWM Lenders","year":"2020","unstructured":"Lenders, J. W. M. et al. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J. Hypertens. 38, 1443\u20131456 (2020).","journal-title":"J. Hypertens."},{"key":"1020_CR109","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022497","volume":"99","author":"YC Huang","year":"2020","unstructured":"Huang, Y. C. et al. Somatic SDHA mutations in paragangliomas in siblings: case report of 2 cases. Medicine 99, e22497 (2020).","journal-title":"Medicine"},{"key":"1020_CR110","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1056\/NEJMc070010","volume":"357","author":"FH van Nederveen","year":"2007","unstructured":"van Nederveen, F. H., Korpershoek, E., Lenders, J. W., de Krijger, R. R. & Dinjens, W. N. Somatic SDHB mutation in an extraadrenal pheochromocytoma. N. Engl. J. Med. 357, 306\u2013308 (2007).","journal-title":"N. Engl. J. Med."},{"key":"1020_CR111","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12672-012-0113-y","volume":"3","author":"A Weber","year":"2012","unstructured":"Weber, A., Hoffmann, M. M., Neumann, H. P. & Erlic, Z. Somatic mutation analysis of the SDHB, SDHC, SDHD, and RET genes in the clinical assessment of sporadic and hereditary pheochromocytoma. Horm. Cancer 3, 187\u2013192 (2012).","journal-title":"Horm. Cancer"},{"key":"1020_CR112","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/hmg\/ddt069","volume":"22","author":"I Comino-Mendez","year":"2013","unstructured":"Comino-Mendez, I. et al. Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis. Hum. Mol. Genet. 22, 2169\u20132176 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"1020_CR113","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1210\/jc.2009-2170","volume":"95","author":"J Gaal","year":"2010","unstructured":"Gaal, J. et al. Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas. J. Clin. Endocrinol. Metab. 95, 1274\u20131278 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1020_CR114","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41436-018-0106-5","volume":"21","author":"S Richter","year":"2019","unstructured":"Richter, S. et al. Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma. Genet. Med. 21, 705\u2013717 (2019).","journal-title":"Genet. Med."},{"key":"1020_CR115","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1093\/hmg\/dds374","volume":"21","author":"N Burnichon","year":"2012","unstructured":"Burnichon, N. et al. Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma. Hum. Mol. Genet. 21, 5397\u20135405 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"1020_CR116","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1093\/hmg\/dds402","volume":"21","author":"J Welander","year":"2012","unstructured":"Welander, J. et al. Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas. Hum. Mol. Genet. 21, 5406\u20135416 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"1020_CR117","doi-asserted-by":"publisher","first-page":"E1266","DOI":"10.1210\/jc.2012-4257","volume":"98","author":"J Crona","year":"2013","unstructured":"Crona, J. et al. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing. J. Clin. Endocrinol. Metab. 98, E1266\u2013E1271 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1020_CR118","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s00268-017-4320-0","volume":"42","author":"J Welander","year":"2018","unstructured":"Welander, J. et al. Activating FGFR1 mutations in sporadic pheochromocytomas. World J. Surg. 42, 482\u2013489 (2018).","journal-title":"World J. Surg."},{"key":"1020_CR119","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","volume":"20","author":"N Burnichon","year":"2011","unstructured":"Burnichon, N. et al. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Hum. Mol. Genet. 20, 3974\u20133985 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"1020_CR120","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","volume":"18","author":"N Burnichon","year":"2012","unstructured":"Burnichon, N. et al. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin. Cancer Res. 18, 2828\u20132837 (2012).","journal-title":"Clin. Cancer Res."},{"key":"1020_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7140","volume":"6","author":"L Fishbein","year":"2015","unstructured":"Fishbein, L. et al. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nat. Commun. 6, 6140 (2015).","journal-title":"Nat. Commun."},{"key":"1020_CR122","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein, L. et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31, 181\u2013193 (2017).","journal-title":"Cancer Cell"},{"key":"1020_CR123","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/gcc.22267","volume":"54","author":"CC Juhlin","year":"2015","unstructured":"Juhlin, C. C. et al. Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene. Genes. Chromosomes Cancer 54, 542\u2013554 (2015).","journal-title":"Genes. Chromosomes Cancer"},{"key":"1020_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41118-8","volume":"14","author":"TD Treger","year":"2023","unstructured":"Treger, T. D. et al. Targetable NOTCH1 rearrangements in reninoma. Nat. Commun. 14, 5826 (2023).","journal-title":"Nat. Commun."},{"key":"1020_CR125","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1042\/CS20220496","volume":"137","author":"BC Belyea","year":"2023","unstructured":"Belyea, B. C. et al. Overexpression of notch signaling in renin cells leads to a polycystic kidney phenotype. Clin. Sci. 137, 35\u201345 (2023).","journal-title":"Clin. Sci."},{"key":"1020_CR126","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41588-024-01714-w","volume":"56","author":"JM Keaton","year":"2024","unstructured":"Keaton, J. M. et al. Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits. Nat. Genet. 56, 778\u2013791 (2024).","journal-title":"Nat. Genet."},{"key":"1020_CR127","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/ng.384","volume":"41","author":"D Levy","year":"2009","unstructured":"Levy, D. et al. Genome-wide association study of blood pressure and hypertension. Nat. Genet. 41, 677\u2013687 (2009).","journal-title":"Nat. Genet."},{"key":"1020_CR128","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41569-020-00466-4","volume":"18","author":"S Padmanabhan","year":"2021","unstructured":"Padmanabhan, S. & Dominiczak, A. F. Genomics of hypertension: the road to precision medicine. Nat. Rev. Cardiol. 18, 235\u2013250 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"1020_CR129","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ng.361","volume":"41","author":"C Newton-Cheh","year":"2009","unstructured":"Newton-Cheh, C. et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet. 41, 666\u2013676 (2009).","journal-title":"Nat. Genet."},{"key":"1020_CR130","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","volume":"50","author":"E Evangelou","year":"2018","unstructured":"Evangelou, E. et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat. Genet. 50, 1412\u20131425 (2018).","journal-title":"Nat. Genet."},{"key":"1020_CR131","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41588-018-0303-9","volume":"51","author":"A Giri","year":"2019","unstructured":"Giri, A. et al. Trans-ethnic association study of blood pressure determinants in over 750,000 individuals. Nat. Genet. 51, 51\u201362 (2019).","journal-title":"Nat. Genet."},{"key":"1020_CR132","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng.3941","volume":"49","author":"J Yang","year":"2017","unstructured":"Yang, J., Zeng, J., Goddard, M. E., Wray, N. R. & Visscher, P. M. Concepts, estimation and interpretation of SNP-based heritability. Nat. Genet. 49, 1304\u20131310 (2017).","journal-title":"Nat. Genet."},{"key":"1020_CR133","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00439-019-02034-4","volume":"139","author":"E Genin","year":"2020","unstructured":"Genin, E. Missing heritability of complex diseases: case solved? Hum. Genet. 139, 103\u2013113 (2020).","journal-title":"Hum. Genet."},{"key":"1020_CR134","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nature08494","volume":"461","author":"TA Manolio","year":"2009","unstructured":"Manolio, T. A. et al. Finding the missing heritability of complex diseases. Nature 461, 747\u2013753 (2009).","journal-title":"Nature"},{"key":"1020_CR135","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jacc.2020.08.014","volume":"76","author":"CW Ives","year":"2020","unstructured":"Ives, C. W., Sinkey, R., Rajapreyar, I., Tita, A. T. N. & Oparil, S. Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review. J. Am. Coll. Cardiol. 76, 1690\u20131702 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1020_CR136","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41591-023-02374-9","volume":"29","author":"MC Honigberg","year":"2023","unstructured":"Honigberg, M. C. et al. Polygenic prediction of preeclampsia and gestational hypertension. Nat. Med. 29, 1540\u20131549 (2023).","journal-title":"Nat. Med."},{"key":"1020_CR137","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ajhg.2018.08.017","volume":"103","author":"MK Freund","year":"2018","unstructured":"Freund, M. K. et al. Phenotype-specific enrichment of mendelian disorder genes near GWAS regions across 62 complex traits. Am. J. Hum. Genet. 103, 535\u2013552 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"1020_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46132-y","volume":"15","author":"X Xu","year":"2024","unstructured":"Xu, X. et al. Genetic imputation of kidney transcriptome, proteome and multi-omics illuminates new blood pressure and hypertension targets. Nat. Commun. 15, 2359 (2024).","journal-title":"Nat. Commun."},{"key":"1020_CR139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001177","volume":"6","author":"S Padmanabhan","year":"2010","unstructured":"Padmanabhan, S. et al. Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet. 6, e1001177 (2010).","journal-title":"PLoS Genet."},{"key":"1020_CR140","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1161\/HYPERTENSIONAHA.113.01423","volume":"63","author":"LA Graham","year":"2014","unstructured":"Graham, L. A. et al. Validation of uromodulin as a candidate gene for human essential hypertension. Hypertension 63, 551\u2013558 (2014).","journal-title":"Hypertension"},{"key":"1020_CR141","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/CIRCRESAHA.121.320625","volume":"131","author":"MR Alexander","year":"2022","unstructured":"Alexander, M. R. et al. A single nucleotide polymorphism in sh2b3\/lnk promotes hypertension development and renal damage. Circ. Res. 131, 731\u2013747 (2022).","journal-title":"Circ. Res."},{"key":"1020_CR142","doi-asserted-by":"publisher","first-page":"100330","DOI":"10.1016\/j.xgen.2023.100330","volume":"3","author":"W Oliveros","year":"2023","unstructured":"Oliveros, W. et al. Systematic characterization of regulatory variants of blood pressure genes. Cell Genom. 3, 100330 (2023).","journal-title":"Cell Genom."},{"key":"1020_CR143","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/ng.3405","volume":"47","author":"N Kato","year":"2015","unstructured":"Kato, N. et al. Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat. Genet. 47, 1282\u20131293 (2015).","journal-title":"Nat. Genet."},{"key":"1020_CR144","doi-asserted-by":"publisher","DOI":"10.1172\/JCI160036","volume":"133","author":"KL Gunawardhana","year":"2023","unstructured":"Gunawardhana, K. L. et al. A systems biology approach identifies the role of dysregulated PRDM6 in the development of hypertension. J. Clin. Investig. 133, e160036 (2023).","journal-title":"J. Clin. Investig."},{"key":"1020_CR145","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.cell.2017.06.049","volume":"170","author":"RM Gupta","year":"2017","unstructured":"Gupta, R. M. et al. A genetic variant associated with five vascular diseases is a distal regulator of endothelin-1 gene expression. Cell 170, 522\u2013533 (2017).","journal-title":"Cell"},{"key":"1020_CR146","doi-asserted-by":"publisher","first-page":"190221","DOI":"10.1098\/rsob.190221","volume":"10","author":"RV Broekema","year":"2020","unstructured":"Broekema, R. V., Bakker, O. B. & Jonkers, I. H. A practical view of fine-mapping and gene prioritization in the post-genome-wide association era. Open Biol. 10, 190221 (2020).","journal-title":"Open Biol."},{"key":"1020_CR147","doi-asserted-by":"publisher","first-page":"100214","DOI":"10.1016\/j.cellin.2024.100214","volume":"4","author":"KN Degner","year":"2025","unstructured":"Degner, K. N., Bell, J. L., Jones, S. D. & Won, H. Just a SNP away: The future of in vivo massively parallel reporter assay. Cell Insight 4, 100214 (2025).","journal-title":"Cell Insight"},{"key":"1020_CR148","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41588-021-00835-w","volume":"53","author":"JM Eales","year":"2021","unstructured":"Eales, J. M. et al. Uncovering genetic mechanisms of hypertension through multi-omic analysis of the kidney. Nat. Genet. 53, 630\u2013637 (2021).","journal-title":"Nat. Genet."},{"key":"1020_CR149","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41586-021-03855-y","volume":"597","author":"Q Wang","year":"2021","unstructured":"Wang, Q. et al. Rare variant contribution to human disease in 281,104 UK Biobank exomes. Nature 597, 527\u2013532 (2021).","journal-title":"Nature"},{"key":"1020_CR150","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599, 628\u2013634 (2021).","journal-title":"Nature"},{"key":"1020_CR151","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1161\/HYPERTENSIONAHA.122.19324","volume":"79","author":"TN Kelly","year":"2022","unstructured":"Kelly, T. N. et al. Insights from a large-scale whole-genome sequencing study of systolic blood pressure, diastolic blood pressure, and hypertension. Hypertension 79, 1656\u20131667 (2022).","journal-title":"Hypertension"},{"key":"1020_CR152","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.172152","volume":"9","author":"I Copeland","year":"2024","unstructured":"Copeland, I. et al. Exome sequencing implicates ancestry-related Mendelian variation at SYNE1 in childhood-onset essential hypertension. JCI Insight 9, e172152 (2024).","journal-title":"JCI Insight"},{"key":"1020_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-014-2295-9","volume":"402","author":"F Pei","year":"2015","unstructured":"Pei, F. et al. Differential expression and DNA methylation of angiotensin type 1A receptors in vascular tissues during genetic hypertension development. Mol. Cell Biochem. 402, 1\u20138 (2015).","journal-title":"Mol. Cell Biochem."},{"key":"1020_CR154","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbrc.2010.04.074","volume":"396","author":"HA Lee","year":"2010","unstructured":"Lee, H. A. et al. Promoter hypomethylation upregulates Na+-K+-2Cl\u2212 cotransporter 1 in spontaneously hypertensive rats. Biochem. Biophys. Res. Commun. 396, 252\u2013257 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1020_CR155","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1161\/HYPERTENSIONAHA.111.182428","volume":"59","author":"HA Lee","year":"2012","unstructured":"Lee, H. A. et al. Tissue-specific upregulation of angiotensin-converting enzyme 1 in spontaneously hypertensive rats through histone code modifications. Hypertension 59, 621\u2013626 (2012).","journal-title":"Hypertension"},{"key":"1020_CR156","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1161\/01.RES.0000258855.60637.58","volume":"100","author":"I Bogdarina","year":"2007","unstructured":"Bogdarina, I., Welham, S., King, P. J., Burns, S. P. & Clark, A. J. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ. Res. 100, 520\u2013526 (2007).","journal-title":"Circ. Res."},{"key":"1020_CR157","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/HYPERTENSIONAHA.124.23451","volume":"82","author":"MR Alexander","year":"2025","unstructured":"Alexander, M. R., Edwards, T. L. & Harrison, D. G. GWAS for defining the pathogenesis of hypertension: have they delivered? Hypertension 82, 573\u2013582 (2025).","journal-title":"Hypertension"},{"key":"1020_CR158","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","volume":"386","author":"B Williams","year":"2015","unstructured":"Williams, B. et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet 386, 2059\u20132068 (2015).","journal-title":"Lancet"},{"key":"1020_CR159","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMoa2507109","volume":"393","author":"JM Flack","year":"2025","unstructured":"Flack, J. M. et al. Efficacy and safety of baxdrostat in uncontrolled and resistant hypertension. N. Engl. J. Med. 393, 1363\u20131374\u00a0(2025).","journal-title":"N. Engl. J. Med."},{"key":"1020_CR160","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","volume":"47","author":"MR Nelson","year":"2015","unstructured":"Nelson, M. R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47, 856\u2013860 (2015).","journal-title":"Nat. Genet."},{"key":"1020_CR161","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1159\/000521626","volume":"146","author":"A Etges","year":"2022","unstructured":"Etges, A. et al. A novel homozygous KLHL3 mutation as a cause of autosomal recessive pseudohypoaldosteronism type II diagnosed late in life. Nephron 146, 418\u2013428 (2022).","journal-title":"Nephron"},{"key":"1020_CR162","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1515\/cclm-2022-0470","volume":"60","author":"G Constantinescu","year":"2022","unstructured":"Constantinescu, G. et al. Integration of artificial intelligence and plasma steroidomics with laboratory information management systems: application to primary aldosteronism. Clin. Chem. Lab. Med. 60, 1929\u20131937 (2022).","journal-title":"Clin. Chem. Lab. Med."}],"updated-by":[{"DOI":"10.1038\/s41581-026-01088-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000}}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01020-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01020-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01020-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T16:04:02Z","timestamp":1778515442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01020-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":162,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1020"],"URL":"https:\/\/doi.org\/10.1038\/s41581-025-01020-6","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"30 September 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41581-026-01088-8","URL":"https:\/\/doi.org\/10.1038\/s41581-026-01088-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Rockefeller University has filed a patent application (PCT\/US2018\/033362, Compositions and methods for diagnosing and treating diseases and disorders associated with mutant KCNJ5), listing U.I.S. as an inventor. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}